Table 5.
The mean ± standard deviation of DAT binding potentials in total striatum and in subregions of the striatum from drug-naïve RLS and Control subjects
| ST | aPU | pPU | aCN | pCN | VS | |
|---|---|---|---|---|---|---|
| Control (N = 34) | 1.65 ± 0.16 | 1.83 ± 0.21 | 1.84 ± 0.16 | 1.65 ± 0.18 | 1.06 ± 0.21 | 1.13 ± 0.28 |
| RLS (N = 9) | 1.40 ± 0.20 | 1.62 ± 0.27 | 1.61 ± 0.28 | 1.46 ± 0.26 | 0.98 ± 0.31 | 0.95 ± 0.29 |
| ANOVA: Control-RLS | F = 16.7 | F = 6.18 | F = 12.5 | F = 6.06 | F = 2.24 | F = 3.25 |
| P = 0.0002 | P = 0.017 | P = 0.001 | P = 0.018 | P = 0.14 | P = 0.08 | |
ST, total striatum; aPU, anterior putamen; pPu, posterior putamen; aCN, anterior caudate nucleus; pCN, posterior caudate nucleus; VS, ventral striatum.